Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: 0.38 + web + 1,650  Related to the article below (Last Update: 8/5/2008)

Flagstar Reports 2008 Second Quarter Results
FOXBusiness - Jul 17, 2008
The conference call and accompanying slide presentation will be webcast live on the Investor Relations section of the Company's Web site, www.flagstar.com, ...FBC - OTC:CMTX
Source: Google News

HIGH BULK EMBOSSED NON WOVEN FIBROUS WEB -
GA Schulz - EP Patent 0,764,228, 2007 - freepatentsonline.com
... of an inch)and most preferably at less than 0.38mm (15 ... as puffier by the displacement
of the web upward between ... 3, -.1553,.1650, is, -.6834,1.2521, 35, .4493,1.0852 ...
-

Effects of withholding fluid in the immediate postnatal period -
JDL Hansen, CA Smith - Pediatrics, 1953 - Am Acad Pediatrics
... http://www.pediatrics.org the World Wide Web at: The online ... 32 39 1650 9.1 36 42
1.20 1.31 1.25 118 70 1.25 ... 3360 9.6 38 31 0.59 0.31 0.23 0.77 0.38 0.24 0.65 ...

Method of making a breathable and liquid impermeable web
BJ Anderson, TL Mansfield, GC Dobrin, S Polat - US Patent 6,605,172, 2003 - freepatentsonline.com
... of about 25? C. to about 120? C. and an engineering strain rate of about 50 s
-1 to about 1650 s -1 , and mechanically modifying said web to form a ...

Composite nonwoven elastic web -
MT Morman - US Patent 4,657,802, 1987 - freepatentsonline.com
... The composite elastic web formed by the disclosed process is also disclosed
and described. ... Shell Technical Bulletin, Kraton G 1650. ...

BREATHABLE AND LIQUID IMPERMEABLE WEB AND METHOD OF MAKING THE WEB -
BJ Anderson, TL Mansfield, GC Dobrin, S Polat - EP Patent 1,246,723, 2004 - freepatentsonline.com
... An engineering strain rate from about 50 s -1 to about 1650 s -1 is found to be
effective in achieving a modified web with desired properties. ...
-

[PDF] Submitted by: Westat 1650 Research Blvd Rockville, MD 20850
N Lerner, R Llaneras, WA Smiley, HF North - rsip.lsu.edu
... Westat 1650 Research Blvd Rockville, MD 20850 ... Content on a CD can also be designed
and structured so that it can be converted to web-based delivery. ...

Gathered nonwoven elastic web. -
MT Morman - EP Patent 0,212,284, 1987 - freepatentsonline.com
... elastomeric materials for use in forming the fibrous nonwoven elastic web 22 include ...
the trade designation KRATON? G, for example, KRATON? G 1650, KRATON? G ...
-

… of prestressed concrete for highway bridges, part I, strength in shear of beams without web -
MA Sozen, EM Zwoyer, CP Siess - ideals.uiuc.edu
... STRENGTH IN SHEAR OF BEAMS WITHOUT WEB REINFORCEMENT /161 --- - - 16" _ - 16" __
zzj*Izzz ... 20 minutes at 1200 F, (3) heating for 45-60 minutes at 1650 F, (4 ...
-

Prediction for Silicon Content in Molten Iron Using a Combined Fuzzy-Associative-Rules Bank -
SH Luo, XG Liu, M Zhao - LECTURE NOTES IN COMPUTER SCIENCE, 2005 - Springer
... Table 2. Time lag of each variable Input variable Sample size Web Time lag (h)
R g ... S1 [52,70] [14.5, 15.6] [7, 10.2] [1200, 1650] [0.30, 0.38] ...

[PDF] Data Sheet -
WD Spatial, R Patterns, HL Output, H Operating, P … - 1999 - atmel.su
... 1650 6300 HLMP-EL30-SVK00* 1650 6300 HLMP-EL32-SV000 1650 6300 HLMP-EJ30-MQ000 ... 1.00
(0.039) MIN. 8.71 ? 0.20 (0.343 ? 0.008) 2.54 ? 0.38 (0.100 ? 0.015) ...
-

Source: Google Scholar
 
 

Zambia: Chemical Condom: Promising HIV/Aids Prevention Cream

The Times of Zambia ( Ndola)

June 28, 2006
Posted to the web June 29, 2006

Darlington Mwendabai

A quest to have a major breakthrough in the fight against HIV/AIDS may soon surface with scientists now coming up with new alternatives such as vaginal creams dubbed Chemical Condom used to block the HIV virus infection in women.

Chemical Condom that is a brain child of renowned United States Meharry Medical College (MMC) director at Comprehensive Centre for Health Disparities Research in HIV, Dr James Hildreth, will also prevent mother-to-child HIV transmission.

With worldwide infection rate of 65 million, Dr Hildreth said research at the Meharry would be done in parallel with Zambia's University Teaching Hospital (UTH) where medical trials would be conducted in an effort to drastically reduce the future HIV infection rate.

History has it that in the 1820s, when a family of former slaves in Kentucky fed and housed an Ohio farmer and then freed his mud-bound wagon, that farmer promised to repay the freemen someday.

Someday arrived 50 years later when, Samuel Meharry reimbursed an act of grace by establishing a medical college for former slaves.

Since the official opening in 1876, Meharry Medical College had upheld a centuries' old value that is to provide to all people irrespective of caste, class, or colour-unrestricted access, with dignity, to health and healing.

Meharry has become one of the America's nation's largest private, independent historically black institutions dedicated to educating health science professionals through seeking solutions to diseases and conditions that disproportionately impact people of colour.

 

The centre for AIDS Health Disparities Research is a recently established research centre funded by National Institutes of Health.

The centre is working to identify factors responsible for the profoundly disproportionate burden of AIDS and HIV infection among minority populations in the United States.

To make this attainable, the centre will focus its effort in three major areas that include basic research, behavioural research and community outreach.

 
Google
Web www.iconocast.com
 

Dr Hildreth with his associate who is a director of Infectious Disease professor, Vladimir Bethaud, were recently in Zambia on a five-day visit from June 18-23, 2006 to seek partnership with UTH management to fight HIV/AIDS in a holistic manner.

In 2001, while at the Johns Hopkins School of Medicine, Dr Hildreth's team discovered cholesterol's instrument role in HIV's ability to infiltrate cells.

Their research culminated in Dr Hildreth developing a vaginal cream that in the laboratory and in animal models blocks the HIV virus and prevents infection.

Investigations indicate that safety was the main concern hence, trial studies in mice proved 95 to 99 per cent successful as professor Berthaud confirmed in an interview.

While in monkeys more than 90 per cent was achieved and now human trials would start before the product was launched soon on the market professor Berthaud further reviews.

The final stage of this research was under way at Meharry, once approved; the cream would be used as antimicrobial agent to prevent the transmission of HIV and other viruses that includes the transmission of mother to child transmission.

"The Chemical Condom that will be packed in cream form will be applied once in seven days by women on their private parts before sex to prevent them from being infected by HIV virus. This way, we hope to make it affordable," Dr Hildreth said.

Women had to use two tea spoons when applying the cream on their private parts but over applying will cause side affects like irritations hence, should be avoided.

He explained that the vagina cream would not have any side affects neither would it kill sperms posing a threat to human production as some critics suggests however, could not warrant a 100 per cent safety as the research was still in its infant stage.

The Chemical Condom is said to block the cholesterol in the virus to avoid mutation once one had unprotected sex with an infected person. The cream that would contain starch sugar that was used as a blockage was found also widely used in many products like drinks, food and other body lotions.

The anti-microbial agent was said to be the natural approach that should be used as an alternative to other existing condoms to also prevent pregnancies but not making women and men impotent as some had suffered.

Dr Hildreth who boasts of 20 years experience in HIV research was in Zambia at the invitation of former Dean in School of Medicine professor, Lupando Munkonge, to enhance partnership with UTH to find an alternative to the fight against the pandemic.

He said despite clinical trials being expensive, exchange programmes would be encouraged between his institutions and UTH henceforth, trials would be done parallel where further research would be intensified.

The visiting doctor said infrastructure was vital and for a country like Zambia like any other development nation, had to incur a lot of money during trial stages in this case UTH needed facilities to start trials.

He disputed the notions that the product would be used to wipe out the black population in the world saying he was black and would not devote his medical work to destruction but would ensure the product was safe and affordable to women.

UTH managing director, Dr Tackson Lambart, disclosed that similar trials were being carried out in Mazabuka in Southern Province.

He welcomed the move to partner with the MMC stating that Chemical Condom was now a national issue that was supposed to be supported by not only the end-users but the citizenly as a whole.

Dr Lambart said the UTH internal medicine department would work closely with MMC to ensure results from research were tangible and beneficial to both rural and urban populace in Zambia and the world over.

Dean in the School of Medicine professor, Yakab Mulla, said Dr Hildreth was a world renowned scientist whose Chemical Condom trials should not be doubted but supported by everyone including UTH and Zambians at large.

Professor Mulla said the partnership with Dr Hildreth's Institution would help serve as a bridge to fill the gap that had been created by the migrating health personnel especially the nurses who had left Zambia for greener pastures.

After all, the "Keep the Promise" on the fight against HIV/AIDS is starting bearing fruits with the invention of the Chemical Condom but the question Zambians and the world were asking is, would this alternative encourage promiscuity among the women retarding the efforts to find a cure for the pandemic? Only time would time.

 

 

Continue News With: H2 ; H3 ; H4 ; H5 ; H6 ; H7 ; H8 ; H9 ; H9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page